Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score

<div>TTP diagnosis and treatment timeline. Major dates in patient’s TTP presentation and treatment course occurring in 2020 are listed along the <i>x</i>-axis with accompanying hash marks and events above. The red scale break on the <i>x</i>-axis signifies large relative gap in time between dates. Daily platelet counts (/<i>µ</i>L) and LDH (U/L) where available are listed below respective dates. The above timeline includes major therapies with which the patient was treated, spanning across dates received including dexamethasone 40 mg (red bar), prednisone 1 mg/kg (blue bar), and plasma exchange (TPE, green bar). Overlapping bars imply multiple treatments given on same days.</div>

Case Reports in Medicine

fig2

Figure 2

Figure 2: Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score 

Figure 2 | Sequential Immune Thrombocytopenia (ITP) and Thrombotic Thrombocytopenic Purpura (TTP) in an Elderly Male Patient with Primary Sjogren’s Syndrome: When in Doubt, Use the PLASMIC Score 